Lazaroid improves intestinal blood flow in the rat during hyperdynamic bacteraemia

British Journal of Surgery

Volumn 84, Issue 12, 1997, Pages 1717-1721

  Krysztopik, R J ^a,c   Bentley, F R ^a   Spain, D A ^b   Wilson, M A ^b   Garrison, R N ^b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; ANTIOXIDANT; FREE RADICAL; LAZAROID;

ANIMAL MODEL; ARTICLE; BACTEREMIA; CONTROLLED STUDY; ENDOTHELIUM CELL; ESCHERICHIA COLI; HEMODYNAMICS; INTESTINE BLOOD FLOW; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROCIRCULATION; MICROSCOPY; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; SEPSIS; VASOCONSTRICTION;

EID: 0030663139     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800841219     Document Type: Article

References (41)

1. Fink MP. Adequacy of gut oxygenation in endotoxemia and sepsis. Crit Care Med 1993; 21(2 Suppl): S4-8.
2. Fry DE. Multiple system organ failure. Surg Clin North Am 1988; 68: 107-22.
3. Hazinski MF, Iberti TJ, MacIntyre NR et al. Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis. Am J Crit Care 1993; 2: 224-37.
4. Lucas CE. The renal response to acute injury and sepsis. Surg Clin North Am 1976; 56: 953-7.
5. Whitworth PW, Cryer HM, Garrison RN, Baumgarten TE, Harris PD. Hypoperfusion of the intestinal microcirculation without decreased cardiac output during live Escherichia coli sepsis in rats. Circ Shock 1989; 27: 111-22.
6. Haglund U. Systemic mediators released from the gut in critical illness. Crit Care Med 1993; 21(2 Suppl): S15-18.
7. Pons L, Droy-Lefaix M, Braquet P, Bueno L. Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances induced by Escherichia coli endotoxins in rats. Gastroenterology 1991; 100: 946-53.
8. Koltai M, Pirotzky E, Braquet P. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure. Nephrol Dial Transplant 1994; 9(Suppl 4): 69-72.
9. Spain DA, Wilson MA, Bar-Natan MF, Garrison RN. Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J Trauma 1994; 36: 720-5.
10. Svartholm E, Arvidsson S, Falt K, Haglund U. Influence of prostanoids on gastrointestinal mucosal injury in experimental septic shock. APMIS 1988; 97: 61-7.
11. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23: 646-51.
12. Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23: 21-48.
13. Nonaka A, Manabe T, Tobe T. Effect of a new synthetic free radical scavenger, 2-octadecyl ascorbic acid, on the mortality in mouse endotoxemia. Life Sc 1990; 47: 1933-9.
14. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ II. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383-7.
15. Thomas PD, Mao GD, Rabinovitch A, Poznansky MJ. Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 21-aminochromans). Biochem Pharmacol 1993; 45: 241-51.
16. Braughler JM, Pregenzer JF. The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals. Free Radic Biol Med 1989; 7: 125-30.
17. Braughler JM, Chase RL, Neff GL et al. A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates adrenocorticotrophin secretion and blocks arachidonic acid release from mouse pituitary tumor (AtT-20) cells. J Pharmacol Exp Ther 1988; 244: 423-7.
18. Isoyama T, Sato T, Tanaka J, Shatney CH. Measurement of cardiac output in small animals by aortic thermodilution. J Surg Res 1982; 33: 170-3.
19. Bohlen HG, Gore RW. Preparation of rat intestinal muscle and mucosa for quantitative microcirculatory studies. Microvasc Res 1976; 11: 103-10.
20. Gore RW, Bohlen HG. Microvascular pressures in the rat intestinal muscle and mucosal villi. Am J Physiol 1977; 233: H685-93.
21. Reilly PM, Bulkley GB. Vasoactivc mediators and splanchnic perfusion. Crit Care Med 1993; 21(2 Suppl): S55-68.
22. Lundgren O, Haglund U. The pathophysiology of the intestinal countercurrent exchanger. Life Sci 1978; 23: 1411-22.
23. Fiddian-Green RG. Associations between intramucosal acidosis in the gut and organ failure. Crit Care Med 1993; 21 (2 Suppl): S103-7.
24. Fiddian-Green RG. Studies in splanchnic ischemia and multiple organ failure. In: Marston A, Bulkley GB, Fiddian-Green RG, Haglund UH, eds. Splanchnic Ischemia and Multiple Organ Failure. London: Edward Arnold, 1989: 349-63.
25. Ward PA, Johnson KJ, Till GO. Oxygen radicals and microvascular injury of lungs and kidney. Acta Physiol Scand Suppl 1986; 548: 79-85.
26. Egan RW, Gale PH, Kuehl FA Jr. Reduction in hydroperoxides in the prostaglandin biosynthetic pathway by a microsomal peroxidase. J Biol Chem 1979; 254: 3295-302.
27. Anderson BO, Bensard DD, Harken AH. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet 1991; 172: 415-24.
28. 2 release by adherent neutrophil leukocytes. J Immunol 1995; 154: 1383-90.
29. 2) in the feline mesenteric vascular bed. Arch Int Pharmacodyn Ther 1979; 241: 214-23.
30. Myers SI, Hernandez R. Role of oxygen-derived free radicals on rat splanchnic eicosanoid production during acute hemorrhage. Prostaglandins 1992; 44: 25-36.
31. Reed MK, Taylor B, Myers SI. The effect of hypoxia on rat splanchnic prostanoid output. Prostaglandins 1989; 38: 599-608.
32. Morrow JD, Roberts LJ II. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996; 51: 1-9.
33. Maridonneau-Parini I, Fradin A, Touqui L et al. Effect of intracellular oxygen free radicals on the formation of lipid derived mediators in rat renomedullary interstitial cells. Biochem Pharmacol 1985; 34: 4137-43.
34. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
35. Powell RJ, Machiedo GW, Rush BF Jr et al. Oxygen free radicals: effect on red cell deformability in sepsis. Crit Care Med 1991; 19: 732-5.
36. Henderson A, Hayes P. Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis: potential new use for an old drug. Ann Phamacother 1994; 28: 1086-8.
37. Fisher M, Levine PH, Cohen RA. A 21-aminosteroid reduces hydrogen peroxide generation by and chemiluminescence of stimulated human leukocytes. Stroke 1990; 21: 1435-8.
38. Epps DE, Knechtel TJ, Bacznskyj O et al. Tirilazad mesylate protects stored erythrocytes against osmotic fragility. Chem Phys Lipids 1994; 74: 163-74.
39. Audus KL, Guillot FL, Braughler JM. Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. Free Radic Biol Med 1991; 11: 361-71.
40. Horton JW, Walker PB. Oxygen radicals, lipid peroxidation, and permeability changes after intestinal ischemia and reperfusion. J Appl Physiol 1993; 74: 1515-20.
41. 2 release is restored by treatment with lazaroid. Prostaglandins 1993; 45: 535-46.